Supplier News Breaks Archives
An advisory committee to the Food and Drug Administration has recommended that GlaxoSmithKline PLC’s (GSK) diabetes drug Avandia should remain on the market, but possibly with tough new restrictions and new warnings.
Dietary supplements supplier NBTY Inc. has agreed to be purchased by private equity firm Carlyle Group for $3.8 billion in one of the biggest private equity deals thus far in 2010.
Pharmaceutical Research and Manufacturers of America (PhRMA) has named John Castellani its new president and chief executive officer, effective September 1.
Merck & Co. is planning to phase out operations at eight research sites and eight manufacturing sites.